Advantage Risk Management Co Ltd
Advantage Risk Management Co Ltd provides healthcare services and equipment, primarily generating revenue through service provision and product sales.
Business. Advantage Risk Management Co Ltd (8769.T) is a healthcare services and equipment company primarily engaged in biotechnology activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in Japan, the company is listed on the Tokyo Stock Exchange. Specific details regarding its operating segments and geographic presence are not disclosed.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Advantage Risk Management Co Ltd (8769.T) is a healthcare services and equipment company primarily engaged in biotechnology activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in Japan, the company is listed on the Tokyo Stock Exchange. Specific details regarding its operating segments and geographic presence are not disclosed.
The company maintains a strong liquidity position, with a current ratio of 1.29 and cash and equivalents amounting to 1,428,867,000 JPY. This liquidity is supported by a low debt-to-equity ratio of 0.09, indicating a conservative capital structure.
Profitability metrics show a return on equity of 7.79% and a return on assets of 4.74%, which are in line with the industry's preferred metrics. The operating income of 442,585,000 JPY and net income of 310,234,000 JPY reflect a healthy margin, suggesting efficient operations.
The company's revenue is primarily concentrated in its core healthcare services and equipment segment, with no significant geographic diversification disclosed. This concentration may pose a risk if the core market experiences downturns.
Looking ahead, the company is projected to maintain its growth trajectory, with a positive outlook for the current and next fiscal years. The operating cash flow of 1,292,086,000 JPY supports this growth, although capital expenditures of -876,246,000 JPY indicate ongoing investment in infrastructure.
Risk factors are minimal, with low liquidity and dilution risks identified. There are no immediate filing-based liquidity or dilution flags, and the dilution potential is low. The company's conservative capital structure and strong cash reserves further mitigate these risks.
Recent events, including the latest financial filings and transcripts, do not indicate any significant changes in the company's strategic direction or operational performance. The company continues to focus on its core healthcare services and equipment segment.
- Advantage Risk Management Co Ltd has a strong liquidity position with a current ratio of 1.29 and significant cash reserves.
- The company's profitability metrics, including a return on equity of 7.79%, are in line with industry standards.
- Revenue is primarily concentrated in the healthcare services and equipment segment, with no significant geographic diversification.
- The company is projected to maintain its growth trajectory, supported by a positive operating cash flow.
- Risk factors are minimal, with low liquidity and dilution risks identified.
- **margin_outlook_rationale**: The company's operating margin is expected to remain stable due to efficient cost management and strong demand for healthcare services.
- **rd_outlook_rationale**: Research and development expenditures are not disclosed, but the company's focus on healthcare services suggests ongoing innovation.
Bull / Bear case
Generated · model-assistedRevenue grew 22.2% year-over-year to JPY 8.55 billion in fiscal 2025, demonstrating strong top-line expansion momentum.
Net income surged 47.2% to JPY 744 million, significantly outpacing revenue growth and indicating robust operational leverage.
Operating margin of 22.1% ranks above the 75th percentile of the Healthcare Facilities & Services cohort median.
Free cash flow improved dramatically by 391.5% to JPY 642 million, marking a strong turnaround from previous deficits.
Cash conversion ratio of 4.16 is best-in-class compared to the cohort median of 1.35, highlighting superior efficiency.
Long-term debt increased sharply to JPY 1.97 billion in fiscal 2025, a significant rise from JPY 345 million prior.
Operating income growth of 8.6% lagged significantly behind the 22.2% revenue growth rate in the latest fiscal year.
Return on assets of 4.74% indicates relatively low asset utilization efficiency compared to the high margin profile.
In focus — financials by report
Revenue ¥2.66B, +3,9% YoY; Operating income −21,6% YoY.
- ▍Revenue ¥2.66B, +3,9% YoY
- ▍Operating income −21,6% YoY
- ▍Net income −19,0% YoY
- ▍Net margin 9.2%
Revenue ¥2.32B, +34,9% YoY; Operating income +204,9% YoY.
- ▍Revenue ¥2.32B, +34,9% YoY
- ▍Operating income +204,9% YoY
- ▍Net income +155,1% YoY
- ▍Net margin 3.9%
Revenue ¥2.24B, +36,5% YoY; Operating income +174,1% YoY.
- ▍Revenue ¥2.24B, +36,5% YoY
- ▍Operating income +174,1% YoY
- ▍Net income +162,6% YoY
- ▍Net margin 4.3%
Revenue ¥2.63B, +31,7% YoY; Operating income −5,9% YoY.
- ▍Revenue ¥2.63B, +31,7% YoY
- ▍Operating income −5,9% YoY
- ▍Net income +82,4% YoY
- ▍Net margin 21.5%
Revenue ¥2.56B; Operating income ¥448.0M.
- ▍Revenue ¥2.56B
- ▍Operating income ¥448.0M
- ▍Net margin 11.9%
Revenue ¥1.72B; Operating income -¥129.1M.
- ▍Revenue ¥1.72B
- ▍Operating income -¥129.1M
- ▍Net margin -9.4%
Revenue ¥1.64B; Operating income ¥52.9M.
- ▍Revenue ¥1.64B
- ▍Operating income ¥52.9M
- ▍Net margin 2.3%
Revenue ¥2.00B; Operating income ¥442.6M.
- ▍Revenue ¥2.00B
- ▍Operating income ¥442.6M
- ▍Net margin 15.5%
Revenue ¥8.55B, +22,2% YoY; Operating income +8,6% YoY.
- ▍Revenue ¥8.55B, +22,2% YoY
- ▍Operating income +8,6% YoY
- ▍Net income +47,2% YoY
- ▍Free cash flow +391,5% YoY
- ▍Net margin 8.7%
Revenue ¥7.00B, +9,3% YoY; Operating income +32,1% YoY.
- ▍Revenue ¥7.00B, +9,3% YoY
- ▍Operating income +32,1% YoY
- ▍Net income +33,9% YoY
- ▍Free cash flow +212,2% YoY
- ▍Net margin 7.2%
Revenue ¥6.41B, +10,6% YoY; Operating income +66,8% YoY.
- ▍Revenue ¥6.41B, +10,6% YoY
- ▍Operating income +66,8% YoY
- ▍Net income +87,1% YoY
- ▍Free cash flow +78,1% YoY
- ▍Net margin 5.9%
Revenue ¥5.79B, +6,2% YoY; Operating income −55,4% YoY.
- ▍Revenue ¥5.79B, +6,2% YoY
- ▍Operating income −55,4% YoY
- ▍Net income −59,3% YoY
- ▍Free cash flow −158,3% YoY
- ▍Net margin 3.5%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Advantage Risk Management Co Ltd Market data — financials · 2026-05-27
- Advantage Risk Management Co Ltd Market data — analyst estimates · 2026-05-27